Gene · 2268
Papers1,862
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 1,862
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SIRT1: A Novel Protective Molecule in Pre-eclampsia. | Int J Med Sci | 2022 | 35813294 | PubTator, text mining | PubMed |
| Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3. | BMC Cancer | 2022 | 35810308 | PubTator, text mining | PubMed |
| Mechanisms of mitochondrial respiratory adaptation. | Nat Rev Mol Cell Biol | 2022 | 35804199 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia. | Mol Ther Oncolytics | 2022 | 35795094 | PubTator, text mining | PubMed |
| Exploring and Expanding Supererogatory Acts: Beyond Duty for a Sustainable Future. | J Bus Ethics | 2022 | 35789620 | PubTator, text mining | PubMed |
| Emerging Proteins in CRPC: Functional Roles and Clinical Implications. | Front Oncol | 2022 | 35756667 | PubTator, text mining | PubMed |
| Interaction mechanism of three egg protein derived ACE inhibitory tri-peptides and DPPC membrane using FS, FTIR, and DSC studies. | Food Chem X | 2022 | 35756460 | PubTator, text mining | PubMed |
| Identification of a Unique Cytotoxic Thieno[2,3-c]Pyrazole Derivative with Potent and Selective Anticancer Effects In Vitro. | Biology (Basel) | 2022 | 35741451 | PubTator, text mining | PubMed |
| Therapeutic inhibition of the SRC-kinase HCK facilitates T cell tumor infiltration and improves response to immunotherapy. | Sci Adv | 2022 | 35731867 | PubTator, text mining | PubMed |
| IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. | Nat Rev Rheumatol | 2022 | 35729334 | PubTator, text mining | PubMed |
| Phosphoregulation of Kinesins Involved in Long-Range Intracellular Transport. | Front Cell Dev Biol | 2022 | 35721476 | PubTator, text mining | PubMed |
| The Role of Alpha-Synuclein Autoantibodies in the Induction of Brain Inflammation and Neurodegeneration in Aged Humans. | Front Aging Neurosci | 2022 | 35721016 | PubTator, text mining | PubMed |
| The landscape of isoform switches in sepsis: a multicenter cohort study. | Sci Rep | 2022 | 35715539 | PubTator, text mining | PubMed |
| Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension. | Front Pharmacol | 2022 | 35712711 | PubTator, text mining | PubMed |
| Computation-Based Discovery of Potential Targets for Rheumatoid Arthritis and Related Molecular Screening and Mechanism Analysis of Traditional Chinese Medicine. | Dis Markers | 2022 | 35707715 | PubTator, text mining | PubMed |
| Identification of Immune-Related Genes in Patients with Acute Myocardial Infarction Using Machine Learning Methods. | J Inflamm Res | 2022 | 35692951 | PubTator, text mining | PubMed |
| Molecular dynamics simulations of the conformational plasticity in the active pocket of salt-inducible kinase 2 (SIK2) multi-state binding with bosutinib. | Comput Struct Biotechnol J | 2022 | 35685353 | PubTator, text mining | PubMed |
| PROTACs: great opportunities for academia and industry (an update from 2020 to 2021). | Signal Transduct Target Ther | 2022 | 35680848 | PubTator, text mining | PubMed |
| Identification of prognostic candidate signatures by systematically revealing transcriptome characteristics in lung adenocarcinoma with differing tumor microenvironment immune phenotypes. | Aging (Albany NY) | 2022 | 35675043 | PubTator, text mining | PubMed |
| SAR Probing of KX2-391 Provided Analogues With Juxtaposed Activity Profile Against Major Oncogenic Kinases. | Front Oncol | 2022 | 35669422 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2268/papers?page=18